Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 31, 2017 Filed Oct 31, 2017 22:15 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 19,016 $145.26 $2,762,264.16
Disclosure

SEC source: 0001209191-17-058479 · doc4.xml · nonDerivative · entry 4

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,124

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.91 to $145.87).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:15 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 25,784 $144.46 $3,724,756.64
Disclosure

SEC source: 0001209191-17-058479 · doc4.xml · nonDerivative · entry 3

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,140

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $144.46 (range $143.90 to $144.89).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:15 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 4,100 $143.46 $588,186.00
Disclosure

SEC source: 0001209191-17-058479 · doc4.xml · nonDerivative · entry 2

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,924

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $143.46 (range $142.87 to $143.85).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:15 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 1,400 $142.38 $199,332.00
Disclosure

SEC source: 0001209191-17-058479 · doc4.xml · nonDerivative · entry 1

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,024

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $142.38 (range $141.83 to $142.81).

F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 500 $149.34 $74,670.00
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 11

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,952

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 1,000 $148.54 $148,540.00
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 10

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,452

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F9 · price: Open market sales reported on this line occurred at a weighted average price of $148.54 (range $148.25 to $149.18).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 5,000 $147.87 $739,350.00
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 9

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,452

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F8 · price: Open market sales reported on this line occurred at a weighted average price of $147.87 (range $147.22 to $148.20).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 7,783 $146.61 $1,141,065.63
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 8

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,452

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $146.61 (range $146.20 to $147.18).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 17,501 $145.34 $2,543,595.34
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 7

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,235

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $145.34 (range $145.05 to $145.87).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 25,999 $144.54 $3,757,895.46
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 6

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,736

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $144.54 (range $144.04 to $145.01).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 5,600 $143.54 $803,824.00
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 5

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,735

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $143.54 (range $143.03 to $144.02).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 11,617 $142.18 $1,651,705.06
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 4

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,335

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $142.18 (range $141.83 to $142.74).

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:18 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 200 $149.34 $29,868.00
Disclosure

SEC source: 0001209191-17-058481 · doc4.xml · nonDerivative · entry 8

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,888

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:18 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 3,791 $148.26 $562,053.66
Disclosure

SEC source: 0001209191-17-058481 · doc4.xml · nonDerivative · entry 7

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,088

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F9 · price: Open market sales reported on this line occurred at a weighted average price of $148.26 (range $147.93 to $148.70).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:18 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 3,500 $147.40 $515,900.00
Disclosure

SEC source: 0001209191-17-058481 · doc4.xml · nonDerivative · entry 6

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,879

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F8 · price: Open market sales reported on this line occurred at a weighted average price of $147.40 (range $146.93 to $147.90).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:18 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 5,200 $146.39 $761,228.00
Disclosure

SEC source: 0001209191-17-058481 · doc4.xml · nonDerivative · entry 5

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,379

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $146.39 (range $145.30 to $146.92).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:18 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 22,464 $145.26 $3,263,120.64
Disclosure

SEC source: 0001209191-17-058481 · doc4.xml · nonDerivative · entry 4

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,579

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.93 to $145.87).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:18 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 32,945 $144.47 $4,759,564.15
Disclosure

SEC source: 0001209191-17-058481 · doc4.xml · nonDerivative · entry 3

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,043

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $144.47 (range $143.91 to $144.89).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:18 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 5,200 $143.47 $746,044.00
Disclosure

SEC source: 0001209191-17-058481 · doc4.xml · nonDerivative · entry 2

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,988

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $143.47 (range $142.91 to $143.85).

Read SEC document
October 31, 2017 Filed Oct 31, 2017 22:18 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 1,700 $142.40 $242,080.00
Disclosure

SEC source: 0001209191-17-058481 · doc4.xml · nonDerivative · entry 1

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,188

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $142.40 (range $141.83 to $142.75).

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
October 27, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,125 $0.00 Strike: $96.87 $0.00
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · derivative · entry 13

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,375

Underlying: Common Stock · 2,125 shares

Expires 2024-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/15/2014.

Read SEC document
October 27, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 2,125 $149.00 $316,625.00
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 3

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,952

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.

Read SEC document
October 27, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
Exercise / conversionCommon Stock 2,125 $96.87 $205,848.75
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 2

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,077

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 27, 2017 Filed Oct 31, 2017 22:16 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 4,165 $141.41 $588,972.65
Disclosure

SEC source: 0001209191-17-058480 · doc4.xml · nonDerivative · entry 1

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,952

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:31 UTC GrantDeferred Stock Units · Derivative 265.376 $155.44 $41,250.05
Disclosure

SEC source: 0001209191-17-057316 · doc4.xml · derivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,857.564

Underlying: Common Stock · 265.376 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) the termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) the termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) the termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:35 UTC
Chodakewitz JeffreyEVP GMDA, CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 1,718 $0.00 Strike: $96.87 $0.00
Disclosure

SEC source: 0001209191-17-057319 · doc4.xml · derivative · entry 6

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,157

Underlying: Common Stock · 1,718 shares

Expires 2024-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/15/2014.

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:35 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 300 $157.38 $47,214.00
Disclosure

SEC source: 0001209191-17-057319 · doc4.xml · nonDerivative · entry 5

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,424

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F2 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:35 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 300 $155.92 $46,776.00
Disclosure

SEC source: 0001209191-17-057319 · doc4.xml · nonDerivative · entry 4

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,724

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F2 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:35 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 818 $154.76 $126,593.68
Disclosure

SEC source: 0001209191-17-057319 · doc4.xml · nonDerivative · entry 3

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,024

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F2 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $154.76 (range $154.50 to $155.15).

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:35 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 300 $153.42 $46,026.00
Disclosure

SEC source: 0001209191-17-057319 · doc4.xml · nonDerivative · entry 2

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,842

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F2 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $153.42 (range $153.11 to $153.58).

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:35 UTC
Chodakewitz JeffreyEVP GMDA, CMO
Exercise / conversionCommon Stock 1,718 $96.87 $166,422.66
Disclosure

SEC source: 0001209191-17-057319 · doc4.xml · nonDerivative · entry 1

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,142

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:41 UTC
SMITH IAN FEVP, COO
Exercise / conversionStock Option (Right to Buy) · Derivative 2,125 $0.00 Strike: $96.87 $0.00
Disclosure

SEC source: 0001209191-17-057320 · doc4.xml · derivative · entry 7

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,375

Underlying: Common Stock · 2,125 shares

Expires 2024-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/15/2014.

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:41 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 200 $157.07 $31,414.00
Disclosure

SEC source: 0001209191-17-057320 · doc4.xml · nonDerivative · entry 5

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,888

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $157.07 (range $156.96 to $157.17).

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:41 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 850 $156.24 $132,804.00
Disclosure

SEC source: 0001209191-17-057320 · doc4.xml · nonDerivative · entry 4

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,088

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $156.24 (range $155.86 to $156.73).

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:41 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 875 $155.03 $135,651.25
Disclosure

SEC source: 0001209191-17-057320 · doc4.xml · nonDerivative · entry 3

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,938

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $155.03 (range $154.75 to $155.52).

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:41 UTC
SMITH IAN FEVP, COO
SaleCommon Stock 200 $154.01 $30,802.00
Disclosure

SEC source: 0001209191-17-057320 · doc4.xml · nonDerivative · entry 2

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,813

F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $154.01 (range $153.58 to 154.43).

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:41 UTC
SMITH IAN FEVP, COO
Exercise / conversionCommon Stock 2,125 $96.87 $205,848.75
Disclosure

SEC source: 0001209191-17-057320 · doc4.xml · nonDerivative · entry 1

SMITH IAN F · CIK 0001197032 · EVP, COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,013

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 12, 2017 Filed Oct 16, 2017 20:59 UTC
Parini MichaelEVP, CL&AO
Exercise / conversionStock Option (Right to Buy) · Derivative 2,125 $0.00 Strike: $90.29 $0.00
Disclosure

SEC source: 0001209191-17-057018 · doc4.xml · derivative · entry 3

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,375

Underlying: Common Stock · 2,125 shares

Expires 2026-07-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/12/2016.

Read SEC document
October 12, 2017 Filed Oct 16, 2017 20:59 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 2,125 $152.93 $324,976.25
Disclosure

SEC source: 0001209191-17-057018 · doc4.xml · nonDerivative · entry 2

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,809

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

Read SEC document
October 12, 2017 Filed Oct 16, 2017 20:59 UTC
Parini MichaelEVP, CL&AO
Exercise / conversionCommon Stock 2,125 $90.29 $191,866.25
Disclosure

SEC source: 0001209191-17-057018 · doc4.xml · nonDerivative · entry 1

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,934

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 21:01 UTC
Chodakewitz JeffreyEVP GMDA, CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 3,437 $0.00 Strike: $73.51 $0.00
Disclosure

SEC source: 0001209191-17-055918 · doc4.xml · derivative · entry 5

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,438

Underlying: Common Stock · 3,437 shares

Expires 2024-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vests in 16 quarterly installments from 1/2/2014.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 21:01 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 600 $152.62 $91,572.00
Disclosure

SEC source: 0001209191-17-055918 · doc4.xml · nonDerivative · entry 4

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,424

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $152.62 (range $152.54 to $152.70).

Read SEC document
October 02, 2017 Filed Oct 4, 2017 21:01 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 1,443 $151.82 $219,076.26
Disclosure

SEC source: 0001209191-17-055918 · doc4.xml · nonDerivative · entry 3

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,024

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $151.82 (range $151.47 to $152.18).

Read SEC document
October 02, 2017 Filed Oct 4, 2017 21:01 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 1,394 $151.04 $210,549.76
Disclosure

SEC source: 0001209191-17-055918 · doc4.xml · nonDerivative · entry 2

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,467

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $151.04 (range $150.37 to $151.36).

F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 21:01 UTC
Chodakewitz JeffreyEVP GMDA, CMO
Exercise / conversionCommon Stock 3,437 $73.51 $252,653.87
Disclosure

SEC source: 0001209191-17-055918 · doc4.xml · nonDerivative · entry 1

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,861

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 12:28 UTC
Graney ThomasChief Financial Officer
GrantCommon Stock 9,566 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-052901 · doc4.xml · nonDerivative · entry 1

Graney Thomas · CIK 0001618275 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,566

F1 · shares: Restricted stock unit award that vests as to 25% of the shares on December 31, 2017 and an additional 25% of the shares on each of September 30, 2018, 2019 and 2020.

Read SEC document
August 31, 2017 Filed Sep 5, 2017 20:42 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
Exercise / conversionStock Option (Right to Buy) · Derivative 1,796 $0.00 Strike: $91.05 $0.00
Disclosure

SEC source: 0001209191-17-051354 · doc4.xml · derivative · entry 3

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,960

Underlying: Common Stock · 1,796 shares

Expires 2026-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016.

Read SEC document
August 31, 2017 Filed Sep 5, 2017 20:42 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
SaleCommon Stock 1,796 $160.00 $287,360.00
Disclosure

SEC source: 0001209191-17-051354 · doc4.xml · nonDerivative · entry 2

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,011

F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1.

Read SEC document
August 31, 2017 Filed Sep 5, 2017 20:42 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
Exercise / conversionCommon Stock 1,796 $91.05 $163,525.80
Disclosure

SEC source: 0001209191-17-051354 · doc4.xml · nonDerivative · entry 1

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,807

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 07, 2017 Filed Aug 9, 2017 20:33 UTC
SMITH IAN FEVP, CFO & COO
Exercise / conversionStock Option (Right to Buy) · Derivative 4,250 $0.00 Strike: $77.31 $0.00
Disclosure

SEC source: 0001209191-17-048255 · doc4.xml · derivative · entry 6

SMITH IAN F · CIK 0001197032 · EVP, CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 4,250 shares

Expires 2024-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/5/2014.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.